Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Esteem Therapeutics
AddedFeb 16, 2024
UpdatedJun 18, 2026
Esteem Therapeutics

Esteem Therapeutics

Pre-Seed

Big data platform providing analytics for data-driven care in the Behavioral Health market.

HQ
Atascadero, CA, US
Founded
2016
Overview
Compare
Fundraising
Employees

Esteem Therapeutics is dedicated to revolutionizing the Behavioral Health market through its big data and analytics platform. The company offers advanced tools that enable data-driven care, enhancing collaboration among healthcare providers. Esteem Therapeutics aims to improve patient outcomes by leveraging comprehensive data insights.

Esteem Therapeutics has made significant strides in the Behavioral Health sector, impacting patient care through its innovative platform. The company's solutions have been adopted by numerous healthcare providers, demonstrating its effectiveness in improving care quality and operational efficiency.

Esteem Therapeutics - Similar Companies

Mental Health Data Services logo

Mental Health Data Services

Empericus logo

Empericus

Behave Health logo

Behave Health

behavehealth.com

Owl Insights logo

Owl Insights

Aware Healthcare logo

Aware Healthcare

awarehc.com

Embold Health logo

Embold Health

emboldhealth.com

Heads Up Health logo

Heads Up Health

headsuphealth.com

Actualize Therapy logo

Actualize Therapy

RX4 Health logo

RX4 Health

rx4.health

Alleva logo

Alleva

helloalleva.com

Ethema Health logo

Ethema Health

ethemahealth.com

Pharma Analytics logo

Pharma Analytics

New Healthcare Enterprises logo

New Healthcare Enterprises

Eon Health logo

Eon Health

Streamlytics logo

Streamlytics

Esteem Therapeutics - Quick Facts

Who are Esteem Therapeutics' competitors?

Companies similar to Esteem Therapeutics include Mental Health Data Services, Empericus, Behave Health and Owl Insights.

When was Esteem Therapeutics founded?

Esteem Therapeutics was founded in 2016.

Where is Esteem Therapeutics' headquarters located?

Esteem Therapeutics' headquarters is located in Atascadero, CA, US.

When was Esteem Therapeutics' last funding round?

Esteem Therapeutics' most recent funding round was for $1M (USD) in October 2019.

How much has Esteem Therapeutics raised to-date?

As of Oct 4, 2019, Esteem Therapeutics has raised a total of $1M (USD).

How many employees does Esteem Therapeutics have?

Esteem Therapeutics has 5 employees as of Feb 4, 2024.

Esteem Therapeutics - Classification

Ownership
  • Private
  • Venture Capital
Technology
  • Analytics
  • Data
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Data Analytics
  • Platform
Tags
  • Healthtech
  • SaaS
NAICS
  • 513200Software Publishers
  • 510000Information
  • 513000Publishing Industries
  • 513210Software Publishers
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7372Prepackaged Software
Show 3 more industry codes
NAICS
  • 518000Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services
  • 518200Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services
  • 518210Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services